Microglial activation states and their implications for Alzheimer's Disease

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Alzheimer's Disease (AD) is characterized by amyloid-beta (Aβ) plaques and tau tangles.
• Microglia, the brain's immune cells, play a critical role in AD pathogenesis.
• Chronic microglial activation leads to neuroinflammation, exacerbating AD pathology.

Purpose of the Study:

• To explore the dual role of microglia in Alzheimer's Disease.
• To investigate the potential of modulating microglial phenotypes for therapeutic benefit.

Main Methods:

• Review of microglial responses to Aβ and NFTs.
• Analysis of pro-inflammatory and anti-inflammatory microglial states.
• Examination of therapeutic strategies targeting microglial phenotypes.

Main Results:

• Microglia can initially clear Aβ but become chronically activated in AD.
• Activated microglia release inflammatory factors, causing neuronal damage and cognitive decline.
• Anti-inflammatory microglial activation shows neuroprotective effects.

Conclusions:

• Microglial phenotype modulation offers a potential dual therapeutic strategy for AD.
• Targeting neuroinflammation alongside plaque pathology may mitigate AD progression.
• Restoring neuroprotective microglial functions is a promising therapeutic avenue.